Objectives: Epithelial-to-mesenchymal transition (EMT) is the initial step enabling the metastasis of cancer cells, which typically leads to death. Although smoking is a major risk factor for lung cancer, there is still widespread use of conventional cigarettes. Recently, the tobacco industry has been transformed by the introduction of electronic cigarettes (ECs), which have lower levels of carcinogens and may provide a safer alternative. Here, we investigate the ability of EC liquids and aerosols to induce an EMT in lung cancer cells.
Introduction
Metastasis is a multi-step process in which cancer cells undergo an epithelial-tomesenchymal transition (EMT), then detach from the primary tumor, and migrate to neighboring or distant organs, where they proliferate and create new tumors [1] . Once cancer cells have metastasized, treatment becomes very difficult, and the chances of survival are diminished.
Lung cancer accounts for the highest number of cancer-related deaths, most of which are due to the metastasis of tumor cells [2, 3] .
Tobacco use is the main risk factor for lung cancer and is responsible for approximately 22% of cancer-related deaths globally [4] . Cigarette smoke promotes metastasis through induction of an EMT in existing airway epithelial tumors by down-regulating epithelial cadherin (E-cadherin), which leads to loss of cell-cell adhesion and apical-basal polarity [5] [6] [7] .
Electronic cigarettes (EC) are tobacco products that have rapidly gained worldwide acceptance and are often promoted as harm-reduction or smoking-cessation alternatives [8] .
Their introduction into world markets has come without much prior research on their potential to cause cancer or effect cancer progression. Prior in vitro studies on EC have focused on their toxicity [9, 10] , with one recent in vitro study showing that EC aerosol produced little mutagenicity [11] . These studies were all done over relatively short exposure periods, usually lasting only 24-48 hours. Other conflicting studies demonstrated that EC exposure results in carcinogenic transformation in Salmonella typhimurium [12] and a rat lung model [13] , which may not be comparable to humans.
No study to date has examined the potential for EC to cause an EMT and contribute to the progression of a pre-existing cancer. In this study, we tested the hypothesis that longer exposures of lung cancer cells to EC liquids and aerosols, typical of those EC users receive, induces an EMT, thereby creating the potential for metastasis.
Materials and Methods

EC liquids and aerosols
Menthol and tobacco flavors of a leading product of cartomizer style EC were purchased at local markets in Southern California. Liquids were removed from cartomizers by centrifugation, and 1% dilutions by volume were prepared in A549 culture medium. Aerosols were generated using a smoking machine by taking 4.3 sec puffs (average for EC users) every 1 minute with an adjusted flow rate to produce a consistent robust puff. Aerosols were collected in A549 culture medium in a 250 mL round-bottom flask, which was suspended in an ethanol and dry ice bath to allow immediate condensation and capture of aerosol puffs. After collection, medium was warmed to room temperature, aliquoted, then immediately frozen and stored at -80 o C until used. Six puffs were dissolved per 1 mL of A549 culture medium, which is referred to as 6 total-puff-equivalents (TPE) of aerosol. Both e-liquids and aerosols were passed through a 0.2µm filter before use in experiments.
Long-term culturing of A549 lung cancer cells
A549 CCL-185 cells (ATCC, Manassas, VA USA), which were previously derived from a human lung adenocarcinoma, were grown on non-coated T-25 flasks and cultured in ATCC F-12 K medium with 10% A549-specific fetal bovine serum in 5% CO2 at 37 o C. Cells were incubated in control medium or medium containing dilutions of aerosol or EC liquid until 80% confluent, then passaged using 0.25% trypsin, and grown in control or treatment medium for 3-8 days.
Morphological analysis
Cell morphology was classified as cobblestone (normal morphology), enlarged, or elongated using CL-Quant (DR Vision, Seattle WA) and CellProfiler image processing software
[14] and a custom machine learning algorithm written in Matlab software (MathWorks Natick, MA, USA). Each image was segmented using CL-Quant software and manually modified to separate individual cells. The binary image of the segmentation was exported into CellProfiler to extract 61 morphological features from which six (area, compactness, eccentricity, major axis length, minor axis length, and solidity) were used to develop a learning library. A library consisting of 126 cells was manually classified to provide ground truth for the three morphological classes. Next, 10-fold cross-validation was conducted resulting in 97% accuracy in classification. Three separate (untrained) datasets consisting of 359 cells were run through the supervised machine learning algorithm and were validated manually, resulting in 89% accuracy. Datasets presented in this paper were automatically analyzed using this classifier.
Immunocytochemistry
Immunocytochemistry was performed using antibodies to EMT markers that included Ecadherin and vimentin (Millipore, Burlington, MA, USA), metalloproteinase 9 (MMP9) and P120 
E-cadherin transfection and internalization
For the E-cadherin/EEA1 co-localization study, cells were first transfected with an Ecadherin-GFP plasmid (Addgene #28009, Cambridge, MA USA). Briefly, cells were plated the day before transfection, a DNA-In A549 transfection reagent was used (MTI-GlobalStem, Gaithersburg, MD USA), and cells were incubated for 18-24 hours to allow gene expression.
Next, the transfected cells were trypsinized and re-plated with EC liquids or aerosol for 4 days.
Lastly, cells were immuno-labeled with an early endosome marker, EEA1, to demonstrate colocalization and internalization of E-cadherin into endocytic vesicles.
To confirm co-localization of E-cadherin and EEA1, a line scanning method was used. Lines with a relative length equivalent to 35 µm were drawn on representative images. Pixel intensity data were collected along the line from both green (E-cadherin) and red (EEA1) channels. To rescale intensity data to a 0 to 1 range, raw intensity data were normalized with the feature scaling equation:
where zi represents the normalized intensity value, which was computed using min and max intensity values in the set x. xi represents the intensity value before normalization. Normalized intensity values were plotted using GraphPad Prism.
Fluorescence and phase contrast microscopy
Time-lapse fluorescent images were collected using an inverted Eclipse Ti-E microscope (Nikon Instruments, Melville, NY) equipped with a 60X objective (numerical aperture 0.85) and captured on the high-resolution Andor Zyla VSC-04941 camera (Andor, Belfast, UK). The live cells were placed in a LiveCell incubation chamber (Pathology Devices Inc., San Diego CA USA), which were kept at 37 o C, 5% CO2, and 90% relative humidity. The images were deconvoluted using the Live De-blur setting in the Nikon NIS Elements software. Fluorescence analysis was quantified using CellProfiler and CL-Quant software (DR Vision, Seattle, WA).
Phase contrast time-lapse videos of A549 cells were captured in a BioStation CT Incubator (Nikon Instruments, Tokyo, Japan).
Motility and Migration Analysis
Phase contrast and Hoechst 33342 (ImmunoChemistry Technologies, Bloomington, MN USA) fluorescent time-lapse images were captured every 15 minutes using a BioStation CT. CLQuant software was used to track and extracted motility information. First, the tophat preprocessing method was used to remove noise and strengthen the signal in the Hoechst (blue) channel (excitation 350nm). Small object removal and background subtraction procedures were applied to minimize background noise. The tracking procedure was applied to the final signal segmentation to create trajectory tracks for cells with fluorescent signal. Tracking data were exported to Excel and imported into Matlab to generate migratory graphs, which displayed the total length traveled and the initial-final position displacement for each cell. Three independent experiments were done for each parameter studied, and statistical analyses were done using one-way ANOVAs with Prism (GraphPad, San Diego, CA USA) and Minitab software (State College, PA USA).
Quantification of β-catenin
β-catenin and P120 were visualized using immunocytochemistry and nuclei were labeled with DAPI-Vectashield (Vector Laboratories, Burlingame, CA USA). For the β-catenin (red channel) signals, images were first smoothed to normalize uneven pixel distribution and rescaled to stretch the fluorescence signal from 0 to 1. Tophat and bottomhat methods were used to enhance the signal, and adaptive MOG thresholding was applied to remove noise.
Otsu's method was used to extract fluorescent β-catenin signals. β-catenin and nuclei segmentations were co-localized. The percent of β-catenin counts or area inside the nucleus was calculated by dividing the co-localized signal by the total β-catenin signal. For both area and count data, statistical analyses were done on arcsine transformed percent data using a one-way ANOVA with Dunnett's post hoc test, in which treated groups were compared to the control.
Quantification of P120 internalization
For P120, images were imported into Cl-Quant for analysis. First, tophat was used to remove haze and background noise. P120 signals were segmented using the threshold method.
The P120 signal was divided into two parts, internalized signal and tight junction signal. At the tight junction, P120 signals were band-like, whereas internalized P120 was punctate. Punctate signals were filtered out based on their size. The remaining signals were then skeletonized to enhance the band-like morphology. Non-band-like signals were then removed by size. The remaining skeletonized band-like signals were used as guides for the co-localization filtering method. Signals that co-localized with skeletonize bands were placed in a tight junction bin and signals that did not were placed in an internalized object bin. Counts and area information were extracted from both bins. The percent of internalized P120 counts or area was extracted by dividing internalized P120 by the total P120 signals. One-way ANOVAs with Dunnett's post hoc test were performed on the percent data, in which treated groups were compared to the control group.
Results
EC E-liquids and aerosols induce morphological changes consistent with an EMT
A549 cells normally grow as tightly adhering "cobblestone" monolayers with a few elongated and large cells interspersed among the cobblestone cells (Fig. 1A) . The relative abundance of each cell type was evaluated using a custom protocol developed with Cl-Quant, CellProfiler, and Matlab software. By 3-4 days of treatment with e-liquid or aerosol, there was a significant decrease in the cobblestone cells and a corresponding increase in single elongated mesenchymal-like cells, consistent with an EMT (Figs. 1A-D) . There was also an increase in the enlarged cells, which were more pronounced in the e-liquid treatments (Figs. 1B, 1D) . In timelapse videos, e-liquid and aerosol treated cells made repeated unsuccessful attempts to adhere with neighboring cells, whereas control cells formed tight cell-to-cell connections (Figs. 1E-G) . In
Figures 1E-G, each individual cell was numbered, and the progeny were followed over time.
Molecular Markers of an EMT
To confirm that the above changes were due to an EMT, molecular markers characteristic of cells transitioning from an epithelial-to-mesenchymal phenotype were used.
Cancer cell-produced MMP9 is required for invasion through the extracellular matrix during metastasis [16] . MMP9 was upregulated by day 4 in A549 cells treated with either E-liquid or aerosol (Figs. 2A, 2C) . By 8 days of treatment, E-cadherin was lost from the cell surface (Fig.   2B ), consistent with the observed lack of cell-to-cell adhesion (Figs. 1E-G) .
Immunocytochemistry also revealed an increase in total vimentin (Figs. 2B, 2D integrated density) and an increase in vimentin cross points, indicative of increased density (Fig. 2E ) after 8 days of treatment. Vimentin is overexpressed in epithelial cancers and facilitates accelerated tumor growth and invasion [17] . These changes in vimentin likely facilitate the transition of cells to a more elongated phenotype. These molecular marker data support the idea that EC treated cells undergo an EMT during 4-8-days of exposure.
Internalization of E-cadherin During the EMT
One of the primary modes of EMT initiation is the reduction of membrane E-cadherin via the endocytic machinery. To assess whether the decrease in E-cadherin expression at the cell membrane was due to its internalization, 4 day-treated A549 cells were transfected with an Ecadherin plasmid and then immuno-labeled with an early endosome marker (EEA1). The control cells revealed very few co-localized signals; whereas both the menthol and tobacco E-liquid and aerosol treated groups had distinct co-labeled puncta indicative of internalized E-cadherin cargo (Figs. 3A-F) . Accumulation of E-cadherin was seen in the perinuclear region (Fig. 3C, white   arrow) 
Treatment with EC liquid and aerosol increases cell motility
An increase in cell motility is characteristic of cancer cells undergoing an EMT [18] . To 
Translocation of β-catenin and P120 from the plasma membrane to the cytoplasm and nucleus
Immunocytochemistry was performed to compare the localization of β-catenin and P120, two adherens junction proteins important in cell polarity, in the control and treated groups. In treated cells, the non-phosphorylated form of β-catenin showed a marked decrease in cell junctions and a corresponding increase inside the cells (Fig. 5A) . If de-phosphorylated, β-catenin is stabilized and protected against degradation by GSK-3β and can move into the nucleus to initiate transcription. Image processing software was used to quantify co-localization of β-catenin with the nuclear DAPI-stain. A significant increase in the number and area (%) of β-catenin puncta in the nucleus was observed in treated cells (Figs. 5B-C) . Treatment of A549 cells with E-liquid or aerosol caused a decrease in P120 at the cell membranes (Fig. 5D ) and an increase in cytoplasmic levels (percent of P120 internalized by area and count shown in Figs. 5E and 5F respectively). Unlike β-catenin, P120 did not show an accumulation in the nuclei of aerosol treated groups (Fig. 5D) , and therefore was not quantified.
Discussion
This study is the first to examine multiday exposure of cancer cells to EC liquids and aerosols and to report that such exposure causes changes in cell morphology, cell-to-cell adhesion, molecular markers, and motility consistent with an EMT. These changes include transformation of cobblestone monolayers to mesenchymal-like cells, decreased E-cadherin, increased vimentin and MMP9, and increased cell motility. There was also an increase in the number of cells with an enlarged phenotype, consistent with a case report in which a lung biopsy from an EC user had multinucleated giant cells [19] . An EMT was induced in A549 cells by both the menthol and tobacco flavored EC liquids and aerosols from the leading product of EC used in this study. This shows that the factor(s) causing the EMT is present in the fluid before heating and is not a chemical produced as a result of aerosolization. EC users do sometimes draw E-liquid into their mouths and get E-liquid on their skin. Although not a topic in this study, there is a possibility that a similar EMT would occur in tumors localized in these tissues as well.
The EC-induced EMT was accompanied by the internalization of E-cadherin via endocytosis into early endosomes with subsequent accumulation in the perinuclear region, which may be the endocytic recycling compartment (ERC) [20] . Loss of E-cadherin from junctional complexes is a ubiquitous feature of an EMT and a necessary step that enables subsequent cell migration away from a tumor during metastasis [18] . We also observed enhanced migration of cells that were no longer able to adhere to other cells.
EC treatment also resulted in the translocation of β-catenin and P120 catenin from the plasma membrane to the cytoplasm, and β-catenin was further translocated to the nucleus. β-catenin and P120 are essential components of the cadherin-based adherens junctions, and their cytoplasmic accumulation likely contributes to the destabilization of cell junctions. Other studies have shown that the transport of these catenins to the nucleus activates the Wnt-signaling (β-catenin) and Rho GTPase (P120) pathways, which in turn contribute to an EMT [20, 21] . The appearance of β-catenin in the nucleus following EC liquid or aerosol treatment suggests that the EMT observed in our study was further activated by the Wnt/β-catenin pathway.
An EMT is a critical initiation step in the metastasis of lung cancer cells. During an EMT, epithelial cells lose their polarity, cell-cell junctions, and cell-matrix adhesions, allowing them to migrate and invade other tissues, often remote from the primary tumor. A549 adenocarcinoma cells are part of the non-small cell lung cancer (NSCLC) group. Once such cells have undergone an EMT and metastasized in patients, treatment is difficult and survival rates are very low (five-year survival rate for stage 4 NSCLC is less than 1%) (American Cancer Society web reference).
ECs are often promoted as harm reduction products, and Public Health England has stated that they are 95% safer than conventional cigarettes [22] . These claims are often based on the observation that EC aerosols have fewer chemicals than conventional cigarettes and harmful chemicals are usually lower in concentration in ECs [23] . However, most work done on cell and animal responses to EC aerosol have not to-date looked for metastasis. One recent paper describes the formation of tumors in rat lungs exposed to EC aerosol [13] . Our data are the first to show an EMT in human lung cancer cells, a critical observation that suggests EC might lead to metastasis of existing tumors. While additional work will be required to determine if a similar EMT occurs in humans using EC, our data demonstrate an important need for additional information on this topic.
Conventional cigarette constituents induce tumor formation and to contribute to cancer progression by initiating an EMT [6, 7, 16, [24] [25] [26] . The effects induced by EC liquids and aerosols are similar to those reported for cigarette smoke, which include morphological changes, increased migratory behavior, and initiation of EMT signaling pathways. This again calls into question the safety of ECs and raises concerns about their designation as harm reduction products.
The aerosol concentration used in our study corresponds to what a user would receive while inhaling 6 puffs of EC aerosol. Although puffing topography varies with each individual [27] , an average user puffs roughly 175 times/day [28] . While our work was done using continuous exposure over multiple days, the concentration of aerosol during our exposures was less than the total exposure an EC user would receive in a day (6 TPE vs 175 puffs/day). It will be important in future work to mimic human inhalation of EC aerosol with in vitro models that use intermittent air liquid interface exposure.
It is not yet known if all products of EC products cause a similar EMT during multiday exposures. Since the EMT was observed with a leading EC product, the number of users who could potentially be impacted is high. This critical finding has significant implications for former cigarette users who have switched to EC and may be at risk for lung cancer or who may already have a lung tumor. Given these findings, it would be advisable for health care workers to include EC use in patient medical records, particularly those with a history of cigarette smoking or dual use of EC and tobacco cigarettes. These data bring to focus the overall need for better understanding of the effects of ECs on health, particularly with respect to cancer progression.
This study further supports the 2016 Surgeon General's conclusion that EC aerosol is not harm-free [8] and that the FDA may need to regulate ECs under its authority. 
